🧠 Stem cells in #ParkinsonsDisease?
At Keck Medicine of USC, Xenos Mason discussed the Phase 1 REPLACE™ trial of iPSC-derived dopaminergic grafts with a focus on safety, graft survival, & dyskinesia monitoring.
Is PD cell replacement nearing proof of concept?
#MovementDisorders #Neurology